mo5 is borne by the malignant cells of 74 % of patients ( n = 27 ) with acute monocytic leukemia ( french-american-british [ fab ] group m4 , m5 ) , and 50 % of patients ( n = 38 ) with acute granulocytic leukemia ( fab m1 , m2 , and m3 ) .
C0334227
malignant cells
C0023467
acute granulocytic leukemia